Authors: Kroger, N Schetelig, J Zabelina, T Kruger, W Renges, H Stute, N Schrum, J Kabisch, H Siegert, W Zander, AR

Citation: N. Kroger et al., A fludarabine-based dose-reduced conditioning regimen followed by allogeneic stem cell transplantation from related or unrelated donors in patients with myelodysplastic syndrome, BONE MAR TR, 28(7), 2001, pp. 643-647

Authors: Kroger, N Zabelina, T Kruger, W Renges, H Stute, N Schrum, J Kabisch, H Schafhausen, P Jaburg, N Loliger, C Schafer, P Hinke, A Zander, AR

Citation: N. Kroger et al., Patient cytomegalovirus seropositivity with or without reactivation is themost important prognostic factor for survival and treatment-related mortality in stem cell transplantation from unrelated donors using pretransplant in vivo T-cell depletion with anti-thymocyte globulin, BR J HAEM, 113(4), 2001, pp. 1060-1071

Authors: Schmitt, C David, K Hiller, J Schrum, J Bredehorst, R Vogel, CW Loliger, C Erttmann, R

Citation: C. Schmitt et al., Natural human IgM antibodies in neuroblastoma therapy: Preliminary resultsfrom a phase I/II therapy study, KLIN PADIAT, 211(4), 1999, pp. 314-318